[Liposome formulations of combretastatin A4 and 4-arylcoumarin analog prodrugs: antitumor effect in the mouse model of breast cancer].

MLA

Mouseeva, E. V., et al. “[Liposome Formulations of Combretastatin A4 and 4-Arylcoumarin Analog Prodrugs: Antitumor Effect in the Mouse Model of Breast Cancer].” Biomeditsinskaia Khimiia, vol. 58, no. 3, May 2012, pp. 326–38. EBSCOhost, https://doi.org/10.18097/pbmc20125803326.

APA

Mouseeva, E. V., Kuznetsova, N. R., Svirshchevskaia, E. V., Bovin, N. V., Sitnikov, N. C., Shavyrin, A. S., Beletskaia, I. P., Combes, S., Fedorov, A. I., & Vodovozova, E. L. (2012). [Liposome formulations of combretastatin A4 and 4-arylcoumarin analog prodrugs: antitumor effect in the mouse model of breast cancer]. Biomeditsinskaia Khimiia, 58(3), 326–338. https://doi.org/10.18097/pbmc20125803326

Chicago

Mouseeva, E V, N R Kuznetsova, E V Svirshchevskaia, N V Bovin, N C Sitnikov, A S Shavyrin, I P Beletskaia, S Combes, A Iu Fedorov, and E L Vodovozova. 2012. “[Liposome Formulations of Combretastatin A4 and 4-Arylcoumarin Analog Prodrugs: Antitumor Effect in the Mouse Model of Breast Cancer].” Biomeditsinskaia Khimiia 58 (3): 326–38. doi:10.18097/pbmc20125803326.